135 related articles for article (PubMed ID: 17515767)
21. Clinical applications of (18)F-FDG in oncology.
Nabi HA; Zubeldia JM
J Nucl Med Technol; 2002 Mar; 30(1):3-9; quiz 10-1. PubMed ID: 11948260
[TBL] [Abstract][Full Text] [Related]
22. Clinical role of F-18 fluorodeoxyglucose positron emission tomography for detection and management of renal cell carcinoma.
Ramdave S; Thomas GW; Berlangieri SU; Bolton DM; Davis I; Danguy HT; Macgregor D; Scott AM
J Urol; 2001 Sep; 166(3):825-30. PubMed ID: 11490227
[TBL] [Abstract][Full Text] [Related]
23. Utility of FDG-PET for staging in a case of mycosis fungoides.
Borella L; Lin M; Cains G; Watson AM; Lin P
Dermatology; 2007; 214(2):185-7. PubMed ID: 17341872
[No Abstract] [Full Text] [Related]
24. In-line (18)F-fluorodeoxyglucose positron emission tomography with computed tomography (PET/CT) in patients with carcinoma of the sinus/nasal area and orbit.
Wild D; Eyrich GK; Ciernik IF; Stoeckli SJ; Schuknecht B; Goerres GW
J Craniomaxillofac Surg; 2006 Jan; 34(1):9-16. PubMed ID: 16343913
[TBL] [Abstract][Full Text] [Related]
25. Futility of fluorodeoxyglucose F 18 positron emission tomography in initial evaluation of patients with T2 to T4 melanoma.
Clark PB; Soo V; Kraas J; Shen P; Levine EA
Arch Surg; 2006 Mar; 141(3):284-8. PubMed ID: 16549694
[TBL] [Abstract][Full Text] [Related]
26. Imaging of cutaneous recurrence of gastric cancer with F-18 FDG positron emission tomography.
Hoffmann M; Oberhuber G; Kletter K; Becherer A; Raderer M
Clin Nucl Med; 2002 Oct; 27(10):731-2. PubMed ID: 12352119
[No Abstract] [Full Text] [Related]
27. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
[TBL] [Abstract][Full Text] [Related]
28. A review of the literature for whole-body FDG PET in the management of patients with melanoma.
Schwimmer J; Essner R; Patel A; Jahan SA; Shepherd JE; Park K; Phelps ME; Czernin J; Gambhir SS
Q J Nucl Med; 2000 Jun; 44(2):153-67. PubMed ID: 10967625
[TBL] [Abstract][Full Text] [Related]
29. F-18 FDG PET/CT imaging of a subcutaneous scalp metastasis from primary carcinoma of the thyroid.
Niederkohr RD; Dadras SS; Leavitt M; McDougall IR
Clin Nucl Med; 2007 Feb; 32(2):162-4. PubMed ID: 17242580
[No Abstract] [Full Text] [Related]
30. Improved detection of second primary cancer using integrated [18F] fluorodeoxyglucose positron emission tomography and computed tomography for initial tumor staging.
Choi JY; Lee KS; Kwon OJ; Shim YM; Baek CH; Park K; Lee KH; Kim BT
J Clin Oncol; 2005 Oct; 23(30):7654-9. PubMed ID: 16234527
[TBL] [Abstract][Full Text] [Related]
31. Utility of combined (18)F-fluorodeoxyglucose-positron emission tomography and computed tomography in patients with cervical metastases from unknown primary tumors.
Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Oral Oncol; 2009 Mar; 45(3):218-24. PubMed ID: 18804404
[TBL] [Abstract][Full Text] [Related]
32. F-18 fluorodeoxyglucose positron emission tomography in the evaluation of distant metastases from renal cell carcinoma.
Majhail NS; Urbain JL; Albani JM; Kanvinde MH; Rice TW; Novick AC; Mekhail TM; Olencki TE; Elson P; Bukowski RM
J Clin Oncol; 2003 Nov; 21(21):3995-4000. PubMed ID: 14581422
[TBL] [Abstract][Full Text] [Related]
33. Extensive bony metastases from facial metatypical basal cell carcinoma: a case report.
Pabst A; Klinghuber M; Müller G; Vandersee S; Werkmeister R
Br J Oral Maxillofac Surg; 2019 Jan; 57(1):82-84. PubMed ID: 30598320
[TBL] [Abstract][Full Text] [Related]
34. Enchondroma: a benign osseous lesion with high F-18 FDG uptake.
Döbert N; Menzel C; Ludwig R; Berner U; Diehl M; Hamscho N; Grünwald F
Clin Nucl Med; 2002 Oct; 27(10):695-7. PubMed ID: 12352108
[TBL] [Abstract][Full Text] [Related]
35. Comparison of (18)F-FDG, (131)I-Na, and (201)Tl in diagnosis of recurrent or metastatic thyroid carcinoma.
Shiga T; Tsukamoto E; Nakada K; Morita K; Kato T; Mabuchi M; Yoshinaga K; Katoh C; Kuge Y; Tamaki N
J Nucl Med; 2001 Mar; 42(3):414-9. PubMed ID: 11337516
[TBL] [Abstract][Full Text] [Related]
36. Acne vulgaris: false-positive finding on integrated 18F-FDG PET/CT in a patient with melanoma.
Pawlik TM; Erasmus JJ; Truong MT; Macapinlac H; Ross MI; Gershenwald JE
AJR Am J Roentgenol; 2006 Jul; 187(1):W117-9. PubMed ID: 16794124
[No Abstract] [Full Text] [Related]
37. F-18 fluorodeoxyglucose PET/CT as an imaging tool for staging and restaging cutaneous angiosarcoma of the scalp.
Vasanawala MS; Wang Y; Quon A; Gambhir SS
Clin Nucl Med; 2006 Sep; 31(9):534-7. PubMed ID: 16921276
[TBL] [Abstract][Full Text] [Related]
38. Comparison of (11)C-choline and (18)F-FDG PET in primary diagnosis and staging of patients with thoracic cancer.
Pieterman RM; Que TH; Elsinga PH; Pruim J; van Putten JW; Willemsen AT; Vaalburg W; Groen HJ
J Nucl Med; 2002 Feb; 43(2):167-72. PubMed ID: 11850480
[TBL] [Abstract][Full Text] [Related]
39. Utility of preoperative [(18)]f fluorodeoxyglucose-positron emission tomography scanning in high-risk melanoma patients.
Brady MS; Akhurst T; Spanknebel K; Hilton S; Gonen M; Patel A; Larson S
Ann Surg Oncol; 2006 Apr; 13(4):525-32. PubMed ID: 16474909
[TBL] [Abstract][Full Text] [Related]
40. Incidental detection of pigmented villonodular synovitis on FDG PET.
Kitapci MT; Coleman RE
Clin Nucl Med; 2003 Aug; 28(8):668-9. PubMed ID: 12897655
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]